Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Different androgen concentrations affect wool-related gene expression differently in Hetian and Karakul sheep breeds.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Henna significantly promotes hair growth and reduces androgen levels in mice with alopecia.

A new compound that could treat various androgen-related conditions was created and analyzed.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

PSA can help diagnose high androgen levels in women.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.